We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

DYNEX

Designs and manufactures fully-automated ELISA microplate workstations, laboratory instruments and associated consuma... read more Featured Products: More products

Download Mobile App




Automated ELISA System Delivers Speed, Precision and Flexibility to Clinical Diagnostic Labs

By LabMedica International staff writers
Posted on 02 Jan 2024

A new fully automated ELISA system featuring the latest enhancements helps achieve powerful lab proficiency while ensuring the security of data to meet all the requirements of 21 CFR Part 11. More...

DYNEX Technologies (Chantilly, VA, USA) has unveiled the Agility Integra fully automated ELISA system that brings speed, precision, and flexibility to clinical diagnostic laboratories. This high-throughput system comes with upgraded software capabilities for powerful results that comply with FDA Regulation 21 CFR Part 11. Agility Integra’s open system takes ELISA testing to the next level, by allowing multiple immunoassays to run simultaneously. It guarantees data integrity and security with improved audit trails, chain of custody, lab information system connectivity, and secure networking.

With Agility Integra, labs can benefit from high-volume, walk-away processing of multiple assays, faster automation and continuous loading of samples, fewer manual processes and improved workflows, and increased lab efficiency and maximum output, among others. Other advantages include enhanced import and export functionality, upgraded data encryption, and optimized reporting. This latest innovation represents the next step in DYNEX’s flagship automated microplate processor and offers unique value for highly regulated laboratory environments.

DYNEX Vice President of Innovation, Rich Bahlmann, views the Agility Integra system as “a true game changer in the realm of clinical research and drug development, offering superior pipetting accuracy and state-of-the-art data protection.” Mr. Bahlmann is confident that the system “will propel clinical research and drug development initiatives forward, paving the way for groundbreaking advancements within the pharmaceutical and biotechnology field.”

Related Links:
DYNEX Technologies


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.